Foghorn Therapeutics (FHTX) Shares Outstanding (Entity) (2019 - 2026)
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Foghorn Therapeutics | 345.02 Mn | 276.94 Mn | - | 58.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.71 Mn |
| Mar 31, 2026 | 58.71 Mn |
| Dec 31, 2025 | 56.66 Mn |
| Sep 30, 2025 | 56.54 Mn |
| Jun 30, 2025 | 55.80 Mn |
| Mar 31, 2025 | 55.72 Mn |
| Dec 31, 2024 | 55.59 Mn |
| Sep 30, 2024 | 55.59 Mn |
| Jun 30, 2024 | 55.33 Mn |
| Mar 31, 2024 | 42.59 Mn |
| Dec 31, 2023 | 42.28 Mn |
| Sep 30, 2023 | 42.22 Mn |
| Jun 30, 2023 | 41.85 Mn |
| Mar 31, 2023 | 41.82 Mn |
| Dec 31, 2022 | 41.80 Mn |
| Sep 30, 2022 | 41.80 Mn |
| Jun 30, 2022 | 41.63 Mn |
| Mar 31, 2022 | 41.43 Mn |
| Dec 31, 2021 | 41.30 Mn |
| Sep 30, 2021 | 37.04 Mn |